Medtronic: Hugo Robotics and innovative procedures double revenue growth

The stock of the medical technology company is currently at a 3-year high. A significant factor in this was the announcement of the latest figures for the second quarter of the fiscal year 2026. After an average revenue growth of only 2.7% over the last four years, revenues increased by 7.5% in the first half of the year compared to the previous year. The robotic-assisted surgical system Hugo is a key driver of long-term growth opportunities. With the medical robot at its back and the prospect of a fifth consecutive revenue record with significantly...